Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations.

Oren Ledder, Wolfram Haller, Richard Tl Couper, Peter Lewindon, Mark Oliver

Journal: Journal of gastroenterology and hepatology 2015;29(12):1954-62

PMID: 25238538

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

This paper, the second in the series, will build on the first and explore the importance of liver and pancreatic manifestations of cystic fibrosis (CF) and the effect on morbidity and mortality of this multifaceted genetic condition. It will also further develop the critical role of the gastroenterologist as part of the multidisciplinary group of clinicians and allied health staff in the effective management of patients with CF.

Address: Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital Parkville, Melbourne, Victoria.

DOI: 10.1111/jgh.12785

Link outs

Free resources

Medical:

Other Literature Sources:

https://scite.ai/reports/25238538

Subscription / membership required

Full Text Sources:

MeSH Terms: Biliary Tract Diseases, Cystic Fibrosis, Diabetes Mellitus, Exocrine Pancreatic Insufficiency, Follow-Up Studies, Humans, Liver Diseases, Pancreatitis